|
DERL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.7909996536124E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.35489999961858E-07 |
| Normal-vs-Stage2 |
5.222500E-03 |
| Normal-vs-Stage3 |
8.01100000000776E-05 |
| Normal-vs-Stage4 |
6.616400E-02 |
| Stage1-vs-Stage2 |
1.596190E-01 |
| Stage1-vs-Stage3 |
4.934100E-02 |
| Stage1-vs-Stage4 |
8.833000E-01 |
| Stage2-vs-Stage3 |
8.235200E-01 |
| Stage2-vs-Stage4 |
3.781000E-01 |
| Stage3-vs-Stage4 |
3.357400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.49300000035413E-08 |
| Normal-vs-AfricanAmerican |
3.32599999985916E-07 |
| Normal-vs-Asian |
3.786200E-01 |
| Caucasian-vs-AfricanAmerican |
4.495900E-02 |
| Caucasian-vs-Asian |
7.263400E-01 |
| AfricanAmerican-vs-Asian |
3.602800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08140000287804E-08 |
| Normal-vs-Female |
5.34839999954961E-07 |
| Male-vs-Female |
1.233990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.284970E-03 |
| Normal-vs-Extreme_Weight |
3.52399999999919E-05 |
| Normal-vs-Obese |
2.1545999995265E-07 |
| Normal-vs-Extreme_Obese |
4.680800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.144600E-01 |
| Normal_Weight-vs-Obese |
4.443700E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.841600E-01 |
| Extreme_Weight-vs-Obese |
4.704300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.188600E-01 |
| Obese-vs-Extreme_Obese |
8.485500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.383200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.17659992859842E-10 |
| Normal-vs-Age(61-80Yrs) |
2.25349999999347E-05 |
| Normal-vs-Age(81-100Yrs) |
2.723200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.160600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.930000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.775640E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.976500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.295300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.396000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.97800031698625E-10 |
| Normal-VS-Type2 PRCC |
5.063100E-03 |
| Normal-VS-KIRP CIMP |
1.944270E-03 |
| Normal-VS-Unclassified PRCC |
4.354200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.358500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.858470E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.985400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.385750E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.520100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.322000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.143700E-03 |
| Normal-vs-N1 |
9.62909999999706E-05 |
| Normal-vs-N2 |
1.594160E-01 |
| N0-vs-N1 |
5.303800E-03 |
| N0-vs-N2 |
1.997600E-01 |
| N1-vs-N2 |
8.854000E-01 |
|
|
